Achillion Pharmaceuticals

About:

A biopharmaceutical company dedicated to transforming the lives of patients and families affected by disorders of the complement system.

Website: http://www.achillion.com

Twitter/X: AchillionPharma

Top Investors: Connecticut Innovations, Advent International, Atlas Venture, Domain Associates, Schroder Ventures

Description:

At Achillion, we are driven to transform the lives of patients and families affected by diseases of the complement system, an integral part of the innate immune system. Scientific and clinical evidence has implicated the complement system, and specifically the complement Alternative Pathway (AP), in numerous devastating diseases and conditions. Our principal focus at Achillion is to advance our clinical-stage portfolio of orally administered factor D inhibitors into late-stage development and potential commercialization for patients with devastating disorders of the complement system.